A new study identifies rare mutations in SPRTN that cause a novel progeroid syndrome. The results point to an unexpected function of SPRTN and bring insight to the mechanisms that link premature aging and cancer.
Change history
12 November 2014
In the version of this article initially published, a sentence on page 1156 stated, "This disease was named SPRTN syndrome," in reference to the genetic syndrome described by Lessel et al. (Nat. Genet. 46, 1239–1244, 2014). However, the article by Lessel et al. did not propose a name for the new syndrome. The error has been corrected in the HTML and PDF versions of the article.
References
Mohaghegh, P. & Hickson, I.D. Hum. Mol. Genet. 10, 741–746 (2001).
Misteli, T. & Scaffidi, P. Nat. Med. 11, 718–719 (2005).
Lessel, D. et al. Nat. Genet. 46, 1239–1244 (2014).
Davis, E.J. et al. Nat. Struct. Mol. Biol. 19, 1093–1100 (2012).
Mosbech, A. et al. Nat. Struct. Mol. Biol. 19, 1084–1092 (2012).
Kim, M.S. et al. Nucleic Acids Res. 41, 1661–1668 (2013).
Stingele, J., Schwarz, M.S., Bloemeke, N., Wolf, P.G. & Jentsch, S. Cell 158, 327–338 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Hiom, K. SPRTN is a new player in an old story. Nat Genet 46, 1155–1157 (2014). https://doi.org/10.1038/ng.3125
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.3125
- Springer Nature America, Inc.
This article is cited by
-
Strategic role of the ubiquitin-dependent segregase p97 (VCP or Cdc48) in DNA replication
Chromosoma (2017)
-
Erratum: Corrigendum: SPRTN is a new player in an old story
Nature Genetics (2015)